Skip to main content

Advertisement

Table 2 Univariate and multivariate analysis for OS

From: A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

Covariate Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Age ≥ 69 years 0.6389 (0.3691–1.1060) 0.057
Sex 1.4 (0.78922.485) 0.247
Weight ≥ 69.5 kg 1.1999 (0.66062.1794) 0.543
Height > 168 cm 0.9492 (0.48841.8445) 0.876
Liver metastasis 3.6912 (2.0123–6.7710) 0.000 3.0637 (1.6693–.623) 0.0003
Lung metastasis 0.4954 (0.2858–0.8587) 0.017 0.6209 (0.3564–1.082 0.0925
Lymph node metastasis 0.4954 (0.2858–0.8587) 0.2723
Only lymph node metastasis 0.4482 (0.2363–0.8502) 0.0145
Brain metastasis 0.9460 (0.4728–1.8927) 0.876
Malignant pleural effusion   0.991
Bone metastasis 1.4029 (0.8022–2.4535) 0.2375
Adrenal gland metastasis 1.1271 (0.5095–2.4933) 0.7689
N. of metastatic sites 1.1610 (0.7966–1.6921) 0.4395
ECOG PS 2.706 (1.774–4.126) < 0.0001 2.588 (1.655–4.046) < 0.0001
Line of treatment 1.1507 (0.7571–1.7488) 0.5133
Global     < 0.0001
  1. Italic values refer to statistically significant covariates (p value < 0.05) for OS